Predict your next investment

Farmalisto company logo
HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer


Series B | Alive

Total Raised


Last Raised

$18M | 9 mos ago

About Farmalisto

Farmalisto is a technology healthcare platform in Latin America that connects providers and users of the healthcare system to enhance value creation and delivery to end customers.

Farmalisto Headquarter Location

Calle 129 A 56 B 23

Bogota, 1103,


(1)492 6363

Latest Farmalisto News

Farmalatam Holding Inc. (Farmalisto) achieves investment of US $ 18 million from the IDB Invest, HBM Healthcare Investments Ltd....

Jan 20, 2021

%PDF-1.7%µµµµ1 0 obj<>/Metadata 75 0 R/ViewerPreferences 76 0 R>>endobj2 0 obj<>endobj3 0 obj<>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.44 841.68] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>endobj4 0 obj<

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Farmalisto

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Farmalisto is included in 1 Expert Collection, including Biopharmaceuticals.



5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Farmalisto Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Farmalisto Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.